Ns Partners LTD Johnson & Johnson Transaction History

Ns Partners LTD

$2.36 Billion
Q3 2024

A detailed history of Ns Partners LTD transactions in Johnson & Johnson stock. As of the latest transaction made, Ns Partners LTD holds 80,955 shares of JNJ stock, worth $11.7 Million. This represents 0.56% of its overall portfolio holdings.

Number of Shares

80,955

Previous 85,348 5.15%

Holding current value

$11.7 Million

Previous $12.5 Million 5.17%

% of portfolio

0.56%

Previous 0.57%

30 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 08, 2024	SELL	$145.48 - $167.38 $639,093 - $735,300	-4,393 Reduced 5.15%	80,955 $13.1 Million
Q2 2024 Aug 08, 2024	SELL	$144.38 - $157.78 $576,220 - $629,699	-3,991 Reduced 4.47%	85,348 $12.5 Million
Q1 2024 May 09, 2024	SELL	$155.22 - $162.74 $718,513 - $753,323	-4,629 Reduced 4.93%	89,339 $14.1 Million
Q4 2023 Feb 09, 2024	SELL	$145.6 - $158.88 $3.72 Million - $4.06 Million	-25,576 Reduced 21.39%	93,968 $14.7 Million
Q3 2023 Nov 13, 2023	SELL	$155.75 - $174.48 $5.62 Million - $6.3 Million	-36,105 Reduced 23.2%	119,544 $18.6 Million
Q2 2023 Aug 10, 2023	BUY	$154.35 - $166.11 $2.75 Million - $2.96 Million	17,845 Added 12.95%	155,649 $25.8 Million
Q1 2023 May 10, 2023	SELL	$151.05 - $180.26 $63,894 - $76,249	-423 Reduced 0.31%	137,804 $21.4 Million
Q4 2022 Feb 10, 2023	SELL	$160.2 - $179.79 $152,830 - $171,519	-954 Reduced 0.69%	138,227 $24.4 Million
Q3 2022 Nov 10, 2022	BUY	$161.33 - $179.52 $520,611 - $579,311	3,227 Added 2.37%	139,181 $22.7 Million
Q2 2022 Aug 05, 2022	BUY	$168.19 - $186.01 $305,096 - $337,422	1,814 Added 1.35%	135,954 $24.1 Million
Q1 2022 May 12, 2022	SELL	$158.14 - $179.59 $1.36 Million - $1.54 Million	-8,600 Reduced 6.02%	134,140 $23.8 Million
Q4 2021 Feb 10, 2022	SELL	$155.93 - $173.01 $1.01 Million - $1.12 Million	-6,457 Reduced 4.33%	142,740 $24.4 Million
Q3 2021 Nov 12, 2021	SELL	$161.5 - $179.47 $2.01 Million - $2.23 Million	-12,416 Reduced 7.68%	149,197 $24.1 Million
Q2 2021 Aug 02, 2021	SELL	$159.48 - $171.07 $1.02 Million - $1.09 Million	-6,392 Reduced 3.8%	161,613 $26.6 Million
Q1 2021 Apr 30, 2021	SELL	$153.07 - $170.48 $2.12 Million - $2.36 Million	-13,869 Reduced 7.63%	168,005 $27.6 Million
Q4 2020 Feb 10, 2021	SELL	$137.11 - $157.38 $175,912 - $201,918	-1,283 Reduced 0.7%	181,874 $28.6 Million
Q3 2020 Nov 12, 2020	BUY	$140.38 - $153.83 $262,931 - $288,123	1,873 Added 1.03%	183,157 $27.3 Million
Q2 2020 Aug 13, 2020	SELL	$128.81 - $155.51 $102,919 - $124,252	-799 Reduced 0.44%	181,284 $25.5 Million
Q1 2020 May 13, 2020	BUY	$111.14 - $153.99 $540,584 - $749,007	4,864 Added 2.74%	182,083 $23.9 Million
Q4 2019 Feb 12, 2020	BUY	$127.5 - $146.44 $826,582 - $949,370	6,483 Added 3.8%	177,219 $25.9 Million
Q3 2019 Nov 13, 2019	SELL	$126.95 - $142.14 $4.89 Million - $5.47 Million	-38,497 Reduced 18.4%	170,736 $22.1 Million
Q2 2019 Aug 07, 2019	BUY	$131.15 - $144.24 $164,330 - $180,732	1,253 Added 0.6%	209,233 $29.1 Million
Q1 2019 May 08, 2019	BUY	$125.72 - $139.79 $37,841 - $42,076	301 Added 0.14%	207,980 $29.1 Million
Q4 2018 Feb 12, 2019	BUY	$122.84 - $147.84 $2.96 Million - $3.56 Million	24,075 Added 13.11%	207,679 $26.8 Million
Q3 2018 Nov 14, 2018	BUY	$121.58 - $142.88 $113,920 - $133,878	937 Added 0.51%	183,604 $25.4 Million
Q2 2018 Aug 02, 2018	SELL	$119.4 - $131.76 $105,072 - $115,948	-880 Reduced 0.48%	182,667 $22.2 Million
Q1 2018 May 15, 2018	BUY	$125.1 - $148.14 $340,647 - $403,385	2,723 Added 1.51%	183,547 $23.5 Million
Q4 2017 Feb 09, 2018	BUY	$131.22 - $143.62 $1.3 Million - $1.43 Million	9,934 Added 5.81%	180,824 $25.3 Million
Q3 2017 Nov 14, 2017	BUY	$129.47 - $135.38 $1.66 Million - $1.74 Million	12,817 Added 8.11%	170,890 $22.2 Million
Q2 2017 Aug 14, 2017	BUY	N/A	158,073	158,073 $20.9 Million

Others Institutions Holding JNJ

# of Institutions

4,275

Shares Held

1.68B

Call Options Held

17.6M

Put Options Held

14.5M

View Full List

About JOHNSON & JOHNSON

Ticker JNJ
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,614,479,872
Market Cap $378B
Description
Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the...

More about JNJ

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Ns Partners LTD, based on Form 13F filings with the SEC.

News

Stay updated on Ns Partners LTD with notifications on news.

Account